Morning Breakouts

Latest KFF Health News Stories

Global AIDS Coordinator Addresses Obama’s Global HIV/AIDS Policy Agenda

Morning Briefing

Speaking at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention on Monday, U.S. Global AIDS Coordinator Eric Goosby outlined President Obama’s global AIDS policy agenda, Plus News/IRIN reports.

House Democrats May Rethink Tax Increases

Morning Briefing

Democratic leaders may scale back a plan to tax the highest American earners after unrest in their own party at the suggestion of a surtax on the wealthy to fund health care reform, The New York Times reports.

Industry Donations Directed To Key Senators

Morning Briefing

Health companies and their employees gave Sen. Max Baucus nearly $1.5 million in 2007 and 2008 just as the Senator was readying the Senate Finance Committee to hear health reform, The Washington Post reports.

State News: Overrides, Cuts And Fraud

Morning Briefing

The Connecticut legislature used its override in both chambers to undo seven Governor vetoes, including one to cover most Connecticut residents, called SustiNet, The Hartford Courant reports.

Medicaid Expansion: Health Care Reform’s Newest Challenge

Morning Briefing

“Until the nation’s governors staged a public revolt last weekend, few people were paying attention to one of the most far-reaching proposals being considered as part of overhauling the health care system: a dramatic expansion and redefinition of the Medicaid program,” Time reports.

GOP Ramps Up Attacks

Morning Briefing

Emboldened by polls indicating rising public anxiety about President Obama’s handling of health-care and the economy, Republicans are launching an effort to link health care proposals to what they say is a failed economic stimulus bill.

South Africa Launches HIV/AIDS Vaccine Trial

Morning Briefing

“The first clinical trial of an HIV/AIDS vaccine designed and developed in South Africa was launched in Cape Town” Monday, the SAPA/The Times reports. The trial will seek to determine the immune response of HIV-negative people to two experimental vaccines